BJDX Bluejay Diagnostics, Inc.
$0.56▼ -4.26%
Healthcare
Other
Volume 98.5K
Avg Volume (10D) 94.3K
Key Metrics & Fundamentals
Market Cap
$2.50M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.56 - 9.52
% vs 50 MA
-34.50%
% vs 200 MA
-70.33%
RSI-14
25.2
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.20
Free Cash Flow
-$1.64M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.30M
COGS
–
Operating Exp
$2.35M
Operating Income
-$2.35M
EBIT
-$2.35M
Pretax Income
-$2.32M
Net Income
-$2.32M
EPS (Diluted)
-1.12
Price & Volume History
Loading chart…
Recent News
Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness
ACCESS Newswire · Oct 13, 2026 6:30 AM ET
Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients
Benzinga · Oct 6, 2026 9:05 AM ET
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
ACCESS Newswire · Oct 6, 2026 6:30 AM ET
Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance
InvestorsHub · Sep 8, 2026 10:55 AM ET
BC-Most Active Stocks
Associated Press · Sep 8, 2026 10:30 AM ET
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
GlobeNewswire · Sep 8, 2026 6:30 AM ET
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
GlobeNewswire · Aug 13, 2026 6:00 AM ET
BC-Most Active Stocks
Associated Press · Aug 5, 2026 10:30 AM ET
Top Premarket Gainers
MT Newswires · Aug 5, 2026 7:26 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BJDX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.